Dr Lal PathLabs Q1 FY25 reported profit above expectations, Share surge 5.67% today
Dr. Lal PathLabs reported strong Q1 FY25 results, beating analyst estimates and driving a 5.67% increase in share price. The company exceeded analyst expectations with a 28% YoY increase in net profit and a 16.4% YoY increase in EBITDA. Dr. Lal PathLabs is benefiting from rising health awareness and increased demand for medical tests, particularly Read more: Dr Lal PathLabs Q1 FY25 reported profit above expectations, Share surge 5.67% today..